Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry

To investigate in-hospital and long-term prognosis in T2DM patients presenting with acute myocardial infarction (AMI) treated with SGLT2-I versus other oral anti-diabetic agents (non-SGLT2-I users). In this multicenter international registry all consecutive diabetic AMI patients undergoing percutane...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Pharmacological research Ročník 187; s. 106597
Hlavní autoři:	Paolisso, Pasquale, Bergamaschi, Luca, Gragnano, Felice, Gallinoro, Emanuele, Cesaro, Arturo, Sardu, Celestino, Mileva, Niya, Foà, Alberto, Armillotta, Matteo, Sansonetti, Angelo, Amicone, Sara, Impellizzeri, Andrea, Esposito, Giuseppe, Morici, Nuccia, Andrea, Oreglia Jacopo, Casella, Gianni, Mauro, Ciro, Vassilev, Dobrin, Galie, Nazzareno, Santulli, Gaetano, Marfella, Raffaele, Calabrò, Paolo, Pizzi, Carmine, Barbato, Emanuele
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier Ltd 01.01.2023
Témata:	Acute Kidney Injury - etiology Acute myocardial infarction Arrhythmias Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy HF hospitalization Humans Myocardial Infarction - drug therapy Outcomes Percutaneous Coronary Intervention - adverse effects Registries Risk Factors SGLT2-I Sodium-Glucose Transporter 2 Inhibitors - adverse effects Treatment Outcome NSTEMI T2DM HF hospitalization Outcomes SGLT2-I OAD PCI STEMI CABG Acute myocardial infarction AMI HF Arrhythmias RWMA
ISSN:	1043-6618, 1096-1186, 1096-1186
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!